{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:46:22Z","timestamp":1768081582490,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7206,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1023\/a:1008380208045","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"479-481","source":"Crossref","is-referenced-by-count":40,"title":["Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity"],"prefix":"10.1016","volume":"11","author":[{"given":"D.","family":"Santini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Di Cosimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gravante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Di Sciascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008380208045_bb0005","first-page":"4024","article-title":"Comparison of the cellular pharmacokinetics and toxicity of 21,21-difluorodeoxycytidine and l-beta-D-arabinofuranosylcytosine","volume":"48","author":"Heinemann","year":"1988","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008380208045_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-199754030-00009","article-title":"Gemcitabine. A review of its pharmacology and clinical potential in NSCLC and pancreatic cancer","volume":"54","author":"Noble","year":"1997","journal-title":"Drugs"},{"key":"10.1023\/A:1008380208045_bb0015","first-page":"4417","article-title":"Evaluation of the antitumor activity of gemcitabine","volume":"50","author":"Hertel","year":"1990","journal-title":"Cancer Res"},{"issue":"10","key":"10.1023\/A:1008380208045_bb0020","first-page":"3","article-title":"Gemcitabine: Preclinical pharmacology and mechanisms of action","volume":"23","author":"Plunkett","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008380208045_bb0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","article-title":"A phase I clinical, plasma, and cellular pharmacology study of gemcitabine","volume":"9","author":"Abbruzzese","year":"1991","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1023\/A:1008380208045_bb0030","first-page":"S7-2","article-title":"Preclinical, pharmacologic, and phase I studies of gemcitabine","volume":"24","author":"Storniolo","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008380208045_bb0035","first-page":"339a","article-title":"Gemcitabine pharmacokinetics are influenced by gender, body surface area (BSA) and duration of infusion","volume":"136","author":"Allerheilingen","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"10","key":"10.1023\/A:1008380208045_bb0040","first-page":"25","article-title":"Phase I studies with the novel nucleoside analog gemcitabine","volume":"23","author":"Abbruzzese","year":"1996","journal-title":"Semin Oncol"},{"issue":"10","key":"10.1023\/A:1008380208045_bb0045","first-page":"32","article-title":"Gemcitabine safety overview","volume":"23","author":"Green","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008380208045_bb0050","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0140-6736(97)06359-9","article-title":"Supraventricular fibrillation (Seminar)","volume":"350","author":"Narayan","year":"1997","journal-title":"Lancet"},{"key":"10.1023\/A:1008380208045_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00001813-199803000-00001","article-title":"Gemcitabine - a safety review","volume":"9","author":"Aapro","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1023\/A:1008380208045_bb0060","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s004320050327","article-title":"Severe non-haematological toxicity after treatment with gemcitabine","volume":"125","author":"Sauer-Heilborn","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1023\/A:1008380208045_bb0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1023\/A:1008305716918","article-title":"Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine","volume":"10","author":"Ciotti","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008380208045_bb0070","series-title":"Pharmacological Basis of Therapy, \u2013 ninth ed","first-page":"901","article-title":"Drugs for the control of gastric acidity and treatment of peptic ulcer disease","author":"Brunton","year":"1996"},{"key":"10.1023\/A:1008380208045_bb0075","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1200\/JCO.1991.9.9.1704","article-title":"Cardiac disturbances during the administration of Taxol","volume":"9","author":"Rowinsky","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008380208045_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJM199907013410109","article-title":"Perspectives on mitral-valve prolapse (Editorial)","volume":"341","author":"Nishimura","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008380208045_bb0085","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"422","article-title":"Adverse reactions to drugs","author":"Wood","year":"1998"},{"key":"10.1023\/A:1008380208045_bb0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0936-6555(98)80033-2","article-title":"Supraventricular arrhythmia: A complication of 5-fluorouracil therapy","volume":"10","author":"Aziz","year":"1998","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1023\/A:1008380208045_bb0095","first-page":"305","article-title":"High-frequency supraventricular arrhythmias induced by a cisplatin-etoposide combination","volume":"80","author":"Petrella","year":"1989","journal-title":"Minerva Med"},{"key":"10.1023\/A:1008380208045_bb0100","series-title":"Heart Disease","first-page":"1901","article-title":"The heart in endocrine and nutritional disorders","author":"Williams","year":"1995"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/4\/479\/7296279\/11-4-479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:15:05Z","timestamp":1582182905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341955027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S092375341955027X"],"URL":"https:\/\/doi.org\/10.1023\/a:1008380208045","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}